BioNTech has finally dosed the first patient with its Herpes Vaccine (BNT163) in a candidate clinical trial. According to the German Vaccine maker, “The vaccine
BioNTech has finally dosed the first patient with its Herpes Vaccine (BNT163) in a candidate clinical trial. According to the German Vaccine maker, “The vaccine